Delivery Order SPE2DB24D2100-SPE2DB25FBEBP
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,228.50, is for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product, to be completed by May 1, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 100S medication. The contract has a ceiling value of $1,056.68 and a performance period through April 24, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,017.77, is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S, a prescription medication product. The delivery order is a firm fixed price contract with a completion date of July 25, 2024. AmerisourceBergen, the prime contractor, does not have a small business set-aside for this award. The contract is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,096.11, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a $1,042.75 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of BUTALB-ACETAMIN-CAF-COD 50-325 100S medication to support military healthcare programs. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award, valued at $1,236.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a performance period extending through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,176.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 100S medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of BUTALB-ACETAMIN-CAFF 50-325-40 100S pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $1,105.65, is a Firm Fixed Price delivery order under an Indefinite Delivery Contract (IDC) held by the prime contractor, Amerisourcebergen Drug Corp. The IDC, designated as SPE2DX, is a $999,999,999.00 global pharmaceutical support vehicle with the DLA Troop Support Medical that extends through December 2026. This contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,061.27, is for the delivery of 4,568,139,083 units of the pharmaceutical product Butalbital-Aspirin-Caffeine Capsules. The contract has an ultimate completion date of May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.87 firm-fixed-price delivery order, awarded on February 11, 2025, is for BUTALBITAL-ASPIRIN-CAFFEINE CP 100S, a pharmaceutical product, with a completion date of February 12, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...